Use of the tumor-infiltrating CD8 to FOXP3 lymphocyte ratio in predicting treatment responses to combination therapy with pertuzumab, trastuzumab, and docetaxel for advanced HER2-positive breast cancer

Use of the tumor-infiltrating CD8 to FOXP3 lymphocyte ratio in predicting treatment responses to combination therapy with pertuzumab, trastuzumab, and docetaxel for advanced HER2-positive breast cancer

Call No. (NDL): UT51-2021-B131
Bibliographic ID of National Diet Library: 032138952

Material type: 博士論文

Author: Koji Takda [著]

Publisher: -

Publication date: [2018]

Material Format: Paper

Capacity, size, etc.: 1冊

Name of awarding university/degree: 大阪市立大学,博士(医学)

View All

Notes on use

Note (General)：: 博士論文

Search by Bookstore

Bibliographic Record

You can check the details of this material, its authority (keywords that refer to materials on the same subject, author's name, etc.), etc.

Paper

Material Type: 博士論文
Title: Use of the tumor-infiltrating CD8 to FOXP3 lymphocyte ratio in predicting treatment responses to combination therapy with pertuzumab, trastuzumab, and docetaxel for advanced HER2-positive breast cancer
Author/Editor: Koji Takda [著]
Author Heading: 髙田, 晃次タカダ, コウジ
Publication Date: [2018]
Publication Date (W3CDTF): 2018
Extent: 1冊
Alternative Title: HER2陽性乳癌に対するペルツズマブ、トラスツズマブ、ドセタキセル併用レジメンでの治療効果に対するTILsのCD8/FOXP3リンパ球比率の有用性 HER2 ヨウセイニュウガンニタイスルペルツズマブ、トラスツズマブ、ドセタキセルヘイヨウレジメンデノチリョウコウカニタイスル TILs ノ CD8/FOXP3 リンパキュウヒリツノユウヨウセイ
Degree grantor/type: 大阪市立大学
Date Granted: 平成30年9月27日
Date Granted (W3CDTF): 2018
Dissertation Number: 甲第3757号
Degree Type: 博士(医学)
Note (Dissertation): 博士論文
Place of Publication (Country Code): JP
Text Language Code: eng
Content Type: テキスト
Media Type: 機器不用
Carrier Type: 冊子
NDLC: UT51
Target Audience: 一般
Note (General): 博士論文
Holding library: 国立国会図書館
Call No.: UT51-2021-B131
Data Provider (Database): 国立国会図書館 : 国立国会図書館蔵書
https://ndlsearch.ndl.go.jp
Bibliographic ID (NDL): 032138952
http://id.ndl.go.jp/bib/032138952
Bibliographic Record Category (NDL): 213